Immunomodulation of nasal epithelial cells by Staphylococcus aureus-derived serine proteases

Journal of Immunology

Volumn 183, Issue 11, 2009, Pages 7592-7601

  Rudack, Claudia ^a   Sachse, Florian ^a   Albert, Nils ^a   Becker, Karsten ^a   Von Eiff, Christof ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Wyeth Pharma GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; TRYPSIN; AUR PROTEIN, STAPHYLOCOCCUS AUREUS; CXCL1 CHEMOKINE; METALLOPROTEINASE;

ARTICLE; BACTERIAL SINUSITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RHINOSINUSITIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; BIOSYNTHESIS; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RHINITIS; SINUSITIS; STAPHYLOCOCCUS INFECTION;

CELLS, CULTURED; CHEMOKINE CXCL1; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; IMMUNOMODULATION; INTERLEUKIN-6; INTERLEUKIN-8; METALLOENDOPEPTIDASES; MIDDLE AGED; NASAL MUCOSA; NF-KAPPA B; RHINITIS; SERINE PROTEASES; SIGNAL TRANSDUCTION; SINUSITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 73349105909     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803902     Document Type: Article

References (33)

1. Niederfuhr, A., H. Kirsche, T. Deutschle, S. Poppert, H. Riechelmann, and N. Wellinghausen. 2008. Staphylococcus aureus in nasal lavage and biopsy of patients with chronic rhinosinusitis. Allergy 63: 1359-1367.
2. Sachse, F., C. von Eiff, K. Becker, M. Steinhoff, and C. Rudack. 2008. Proin- flammatory impact of Staphylococcus epidermidis on the nasal epithelium quantified by IL-8 and GRO-α responses in primary human nasal epithelial cells. Int. Arch. Allergy Immunol. 145: 24-32. (Pubitemid 350275250)
3. Proctor, R. A., C. von Eiff, B. C. Kahl, K. Becker, P. McNamara, M. Herrmann, and G. Peters. 2006. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4: 295-305.
4. Clement, S., P. Vaudaux, P. Francois, J. Schrenzel, E. Huggler, S. Kampf, C. Chaponnier, D. Lew, and J. S. Lacroix. 2005. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J. Infect. Dis. 192: 1023-1028.
5. Meltzer, E. O., D. L. Hamilos, J. A. Hadley, D. C. Lanza, B. F. Marple, R. A. Nicklas, C. Bachert, J. Baraniuk, F. M. Baroody, M. S. Benninger, et al. 2004. Rhinosinusitis: establishing definitions for clinical research and patient care. J. Allergy Clin. Immunol. 114: 155-212. (Pubitemid 39575875)
6. Bachert, C., N. Zhang, J. Patou, T. van Zele, and P. Gevaert. 2008. Role of staphylococcal superantigens in upper airway disease. Curr. Opin. Allergy Clin. Immunol. 8: 34-38.
7. Patou, J., P. Gevaert, T. van Zele, G. Holtappels, P. Van Cauwenberge, and C. Bachert. 2008. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J. Allergy Clin. Immunol. 121: 110-115.
8. O'Brien, G. J., G. Riddell, J. S. Elborn, M. Ennis, and G. Skibinski. 2006. Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells. Respir. Res. 7: 115.
9. Karlsson, A., and S. Arvidson. 2002. Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA. Infect. Immun. 70: 4239-4246. (Pubitemid 34790932)
10. Boles, B. R., and A. R. Horswill. 2008. agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 4: e1000052.
11. Böhm, S. K., E. F. Grady, and N. W. Bunnett. 1997. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem. J. 322: 1-18.
12. Rudack, C., M. Steinhoff, F. Mooren, J. Buddenkotte, K. Becker, C. von Eiff, and F. Sachse. 2007. PAR-2 activation regulates IL-8 and GRO-α synthesis by NF-κB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium. Clin. Exp. Allergy 37: 1009-1022.
13. Rudack, C., S. Maune, J. Eble, and J. M. Schroeder. 2003. The primary role in biologic activity of the neutrophil chemokines IL-8 and GRO-α in cultured nasal epithelial cells. J. Interferon Cytokine Res. 23: 113-123. (Pubitemid 36356881)
14. Becker, K., R. Roth, and G. Peters. 1998. Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene. J. Clin. Microbiol. 36: 2548-2553. (Pubitemid 28380953)
15. Griego, S. D., C. B. Weston, J. L. Adams, R. Tal-Singer, and S. B. Dillon. 2000. Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J. Immunol. 165: 5211-5220.
16. Jonsson, I. M., C. von Eiff, R. A. Proctor, G. Peters, C. Rydén, and A. Tarkowski. 2003. Virulence of a hemB mutant displaying the phenotype of a Staphylococcus aureus small colony variant in a murine model of septic arthritis. Microb. Pathog. 34: 73-79.
17. Vaudaux, P., P. Francois, C. Bisognano, W. L. Kelley, D. P. Lew, J. Schrenzel, R. A. Proctor, P. J. McNamara, G. Peters, and C. von Eiff. 2002. Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect. Immun. 70: 5428-5437.
18. Von Eiff, C., P. McNamara, K. Becker, D. Bates, X. H. Lei, M. Ziman, B. R. Bochner, G. Peters, and R. A. Proctor. 2006. Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colonyvariant phenotype. J. Bacteriol. 188: 687-693. (Pubitemid 43100556)
19. Foster, T. J. 2004. The Staphylococcus aureus "superbug." J. Clin. Invest. 114: 1693-1696.
20. Seggewiss, J., K. Becker, O. Kotte, M. Eisenacher, M. R. Khoschkhoi Yazdi, A. Fischer, P. McNamara, N. Al Laham, R. Proctor, G. Peters, et al. 2006. Reporter metabolite analysis of transcriptional profiles of a Staphylococcus aureus strain with normal phenotype and its isogenic hemB mutant displaying the smallcolony- variant phenotype. J. Bacteriol. 188: 7765-7777.
21. Kohler, C., C. von Eiff, G. Peters, R. A. Proctor, M. Hecker, and S. Engelmann. 2003. Physiological characterization of a heme-deficient mutant of Staphylococcus aureus by a proteomic approach. J. Bacteriol. 185: 6928-6937.
22. Li, J. D. 2003. Exploitation of host epithelial signaling networks by respiratory bacterial pathogens. J. Pharmacol. Sci. 91: 1-7.
23. Imasato, A., C. Desbois-Mouthon, J. Han, H. Kai, A. C. Cato, S. Akira, and J. D. Li. 2002. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of Toll-like receptor 2. J. Biol. Chem. 277: 47444-47450.
24. Megyeri, P., L. Németh, K. M. Pabst, M. J. Pabst, M. A. Deli, and C. S. Ábrahám. 1999. 4-(2-Aminoethyl)benzenesulfonyl fluoride attenuates tumor-necrosis-factor-α-induced blood-brain barrier opening. Eur. J. Pharmacol. 374: 207-211.
25. Winton, H. L., H. Wan, M. B. Cannell, D. C. Gruenert, P. J. Thompson, D. R. Garrod, G. A. Stewart, and C. Robinson. 1998. Cell lines of pulmonary and non-pulmonary origin as tools to study the effects of house dust mite proteinases on the regulation of epithelial permeability. Clin. Exp. Allergy 28: 1273-1285.
26. Fukakusa, M., C. Bergeron, M. K. Tulic, P. O. Fiset, O. Al Dewachi, M. Laviolette, Q. Hamid, and J. Chakir. 2005. Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-γ-inducible protein 10 expression in asthmatic airway mucosa. J. Allergy Clin. Immunol. 115: 280-286. (Pubitemid 40215090)
27. Rudack, C., C. Bachert, and W. Stoll. 1999. Effect of prednisolone on cytokine synthesis in nasal polyps. J. Interferon Cytokine Res. 19: 1031-1035. (Pubitemid 29445060)
28. Vliagoftis, H., A. D. Befus, M. D. Hollenberg, and R. Moqbel. 2001. Airway epithelial cells release eosinophil survival-promoting factors (GM-CSF) after stimulation of proteinase-activated receptor 2. J. Allergy Clin. Immunol. 107: 679-685. (Pubitemid 32397757)
29. De Caterina, R., P. Libby, H. B. Peng, V. J. Thannickal, T. B. Rajavashisth, M. A. Gimbrone, Jr., W. S. Shin, and J. K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96: 60-68.
30. Kopp, E., and S. Ghosh. 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265: 956-959.
31. Pierce, J. W., M. A. Read, H. Ding, F. W. Luscinskas, and T. Collins. 1996. Salicylates inhibit IκB-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J. Immunol. 156: 3961-3969.
32. Weber, C., W. Erl, A. Pietsch, and P. C. Weber. 1995. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91: 1914-1917.
33. Pierce, J. W., R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, and M. E. Gerritsen. 1997. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272: 21096-21103.